QA: BELLICUM PHARMACEUTICALS INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2018_BELLICUM_PHARMACEUTICALS_INC.pdf

Logs

Graph

Absolute values for 0001358403, BELLICUM PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 101,650,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 25,942,000
3 remainder_Assets 7,936,000
4 LiabilitiesCurrent 12,156,000
5 LiabilitiesNoncurrent 34,946,000
6 remainder_Liabilities 3,778,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,045,000
9 ResearchAndDevelopmentExpense 65,663,000
10 remainder_Expenses 864,000
11 remainder_Revenues 185,000
12 remainder_NetIncome -4,392,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 135,528,000
1 Liabilities 50,880,000
2 Expenses 87,572,000
3 Revenues 185,000
4 StockholdersEquity 84,648,000
5 NetIncome -91,779,000
6 ComprehensiveNetIncome -91,779,000
7 BaseVar 139,278,500
8 EconomicCapitalRatio 0.577

Edgar->Model Mapping

Feature Distribution

Change over Time